| Article Access Statistics|
| Viewed||379 |
| Printed||11 |
| Emailed||0 |
| PDF Downloaded||71 |
| Comments ||[Add] |
Click on image for details.
|Year : 2017
: 20 | Issue : 2 | Page
|Myocardial revascularization without extracorporeal circulation; Why hasn't it convinced yet?
Efstratios Apostolakis1, Nikolaos A Papakonstantinou2, Ioanna Koniari3
1 Department of Cardiothoracic Surgery, University Hospital of Ioannina, School of Medicine, 45500 Ioannina, Greece
2 Department of Cardiothoracic Surgery, General Hospital of Athens “Evangelismos”, Athens, Greece
3 Department of Cardiothoracic Surgery, University Hospital of Patras, School of Medicine, Rion 26500, Patras, Greece
Click here for correspondence address and
|Date of Web Publication||6-Apr-2017|
| Abstract|| |
Extracorporeal circulation has led to a great development in cardiovascular surgery during the last five decades. Its time-proven efficacy and safety have made on-pump coronary artery bypass grafting (CABG) the gold standard method of surgical revascularization. However, coronary revascularization on cardiopulmonary bypass and the accompanying aortic manipulation are related to plenty of deleterious complications. Therefore, off-pump CABG surgery was established to avoid complications. Nevertheless, despite the initial enthusiasm on this technique, only 20% of myocardial revascularization procedures worldwide are performed off-pump. Not only are off-pump cardiac procedures more technically difficult but also they do not provide better results in terms of graft patency, completeness of revascularization, repeat revascularization requirement, cost, and quality of life. Completeness of revascularization and anastomotic quality should not be compromised to avoid cardiopulmonary bypass.
Keywords: Coronary artery bypass grafting, off-pump, on-pump, myocardial revascularization
|How to cite this article:|
Apostolakis E, Papakonstantinou NA, Koniari I. Myocardial revascularization without extracorporeal circulation; Why hasn't it convinced yet?. Ann Card Anaesth 2017;20:219-25
|How to cite this URL:|
Apostolakis E, Papakonstantinou NA, Koniari I. Myocardial revascularization without extracorporeal circulation; Why hasn't it convinced yet?. Ann Card Anaesth [serial online] 2017 [cited 2017 Oct 17];20:219-25. Available from: http://www.annals.in/text.asp?2017/20/2/219/203955
| Introduction|| |
Thorough comparisons between on-pump (ONCAB) and off-pump (OPCAB) coronary artery bypass surgery have not managed to answer which is the ideal surgical strategy yet. Certainly, extracorporeal circulation has led to a great development in cardiovascular surgery during the last five decades. Its time-proven efficacy and safety have made ONCAB the gold standard method of surgical revascularization. However, coronary revascularization on cardiopulmonary bypass (CPB) and the accompanying aortic manipulation are related to plenty of complications, such as myocardial ischemic injury, coagulation disorders, neurocognitive deficits, strokes, complement activation, and systemic inflammatory response which may lead to renal failure, pulmonary, or hematologic complications., These deleterious effects of CPB and aortic manipulation were the reasons why coronary artery bypass grafting (CABG) without the use of extracorporeal circulation, the so-called OPCAB was established. OPCAB, having the potential to decrease perioperative morbidity, mortality, and cost, expanded worldwide; and nowadays, some centers have adopted it as the method of choice for the treatment of coronary artery disease. Indeed, 95% of cardiac revascularization procedures in India are performed off-pump, whereas 25% of them concerned OPCAB in North America in 2004. Nevertheless, despite the initial enthusiasm on OPCAB, a plateau has been reached in recent years, and currently, OPCAB accounts for only 20% of myocardial revascularization procedures worldwide, whereas the heart-lung machine is still used in 80% of them., OPCAB is considered a more technically challenging and demanding approach , but are the difficulty of the technique and the longer learning curve both for the surgeon and the anesthesiologist to put the blame on? Of course not. There are also additional factors that discourage the surgeon from practicing this operation, including graft patency, completeness of revascularization, and repeat revascularization requirement. Herein, we will try to shed light on the disadvantages of OPCAB and to indicate if OPCAB can play a role in the myocardial revascularization field.
| Off-pump Coronary Artery Bypass Indications|| |
The indications for OPCAB have expanded through the years as we become more experienced and more familiar with the technical difficulties of this method. The International Society for Minimally Invasive Cardiothoracic Surgery recommendations states that perioperative morbidity, neurocognitive dysfunction, and hospitalization are decreased through OPCAB, so high-risk patients having severe ascending aortic calcification, liver disease, renal insufficiency, or other systemic processes should be candidates for OPCAB to reduce morbidity and mortality. According to the American Heart Association Guidelines in 2011, both ONCAB and OPCAB are reasonable, depending on patient's characteristics. Hence, a patient having a heavily calcified ascending aorta can gain profit from OPCAB. On the other hand, the European Guidelines (2010) do not state anything for OPCAB indications. The elderly and the patients with the left main stem coronary artery disease, impaired left ventricular function, a porcelain aorta, right coronary artery disease, non-STEMI, or pulmonary edema are more often candidates for OPCAB. In high-risk patients, such as in very old patients, postoperative neurological complications and intubation duration are increased when on-pump CABG is performed. However, according to Harold Lazar's review published in “Circulation” in 2013, myocardial revascularization through OPCAB can offer a clear profit only in patients with a porcelain or atherosclerotic aorta having an increased risk for aortic trauma or cerebral embolization and in patients with liver failure or cirrhosis, in whom there is a need to avoid prolonged heparinization periods. Finally, high-risk patients might gain profit from OPCAB use.
| Quality-quantity of Distal Anastomoses|| |
It is obvious that performing distal anastomoses on a beating heart and in a bloody surgical field is quite more difficult. Surgical conditions provided by OPCAB, such as the hazard of partial occlusion of coronary arteries, the endooccluders placement and the use of CO2 blowers, are undoubtedly inferior to the nearly ideal conditions ensured during on-pump CABG. Furthermore, during OPCAB, patients are more prone to significant local damage of the vascular endothelium contributing to local thrombosis. In addition, despite advances in OPCAB equipment, inferior and posterolateral coronary vessels are more difficult to be grafted through OPCAB. Such anastomoses require significant heart moving leading to hemodynamic instability, so they may be frequently performed more distally on the coronary branches during OPCAB than during on-pump CABG. As a result, a double risk is noticed: an inevitably smaller diameter anastomosis, thus being more prone to thrombosis, and retrograde flow for a bigger part of the ischemic myocardium. Moreover, a cardiac surgeon more easily excludes a thinner or a having obvious damages coronary vessel from being the target vessel during OPCAB. Therefore, OPCAB is related to a lower mean of distal anastomoses, when compared to on-pump CABG. When 1 diseased vascular segment is not revascularized, no mortality risk increase occurs. Nevertheless, 2 unrevascularized vascular segments lead to significantly increased mortality risk (P = 0.01). Shroyer et al. reported that OPCAB was related to fewer than originally planned grafts performed in comparison with ONCAB (17.8% vs. 11.1%, P < 0.001). Significantly, fewer graft anastomoses per patient in OPCAB versus ONCAB are performed.,
| In-hospital Mortality|| |
None of the two methods seems to be superior with regard to 30-day mortality according to the international literature. No difference in 30-day mortality was reported by Shroyer et al. in the largest (2203 patients), multicenter, randomized trial to date comparing OPCAB with ONCAB. Racz et al., retrospectively comparing 59,000 patients who received ONCAB with 9000 patients who received OPCAB, found no difference in 30-day mortality, as well as in risk-adjusted in-hospital mortality. Hannan et al., retrospectively comparing 13889 OPCAB cases versus 35941 ONCAB cases, observed no difference in 30-day mortality. Moreover, OPCAB was accompanied by lower risk-adjusted mortality rates (P = 0.002). Nevertheless, the 30-day mortality rate was 9.73% in the 226 patients who were converted from OPCAB to on-pump CABG. Li et al. as well as Puskas et al. reported a decrease in risk-adjusted operative mortality in their large retrospective studies. No significant difference in terms of in-hospital mortality was either found in many other retrospective studies by Chu et al., by Palmer et al., by Williams et al., and by Sabik et al. Similar results have also been extracted by numerous meta-analyses. In a meta-analysis of 57 trials including 5200 patients by Møller et al., no statistically significant difference in mortality between OPCAB and on-pump CABG was noticed. However, the authors reported that approximately 242,000 patients should be included to extract reliable outcomes concerning the real difference between the two approaches in terms of mortality. Similarly, Cheng's et al. meta-analysis of 37 nonrandomized trials, including 3369 patients, revealed no statistically significant superiority in 30-day mortality. Neither Feng et al., analyzing 10 randomized trials in approximately 2000 patients, noticed any significant difference between on-pump CABG and OPCAB neither in early (30-day) peri-operative mortality nor in late (12-month) mortality. Furthermore, in a propensity score analysis by Kuss et al. comparing the two methods in approximately 123,000 patients, OPCAB was superior to on-pump CABG, having a lower perioperative mortality rate. According to Murzi et al., CPB was an independent predictor of in-hospital mortality (odds ratio 5.74; P = 0.001) and OPCAB was associated to lower in-hospital mortality (0.5% vs. 2.9%; P = 0.001). Jarral et al. observed a significant reduction in 30-day mortality in patients with left ventricular dysfunction. Finally, Fattouch et al., comparing OPCAB to ONCAB in their prospective study, reported that patients who underwent emergency surgery within 6 h of the onset of symptoms due to ST-segment elevation myocardial infarction (NSTEMI) with cardiogenic shock took advantage of OPCAB in terms of in-hospital mortality.
Early Postoperative Complications
Many randomized studies have shown that blood loss after OPCAB is significantly less than after on-pump CABG. That is the reason why OPCAB requires a significantly smaller number of red packed-cell and clotting-product transfusions.,, Hu et al. examining 6665 patients as well as a meta-analysis by Cheng et al. have shown a statistically significant less need for transfusion when OPCAB is used. Similar conclusions were extracted by a propensity score analysis by Kuss et al. According to Racz et al., reoperation surgery because of bleeding was significantly more frequent after ONCAB (2.2% vs. 1.6%; P < 0.001). OPCAB was also more rarely related to reoperation due to bleeding within 30 days of surgery in Reston et al. study, including 46,621 patients.
Microemboli and the inevitable ischemic time after clamping the aorta are the main harmful effects of extracorporeal circulation on the coronary circulation. Both randomized and nonrandomized, comparative studies have noticed a smaller increase in cardiac enzymes (creatine kinase-MB [CK-MB] and troponin) in the group of OPCAB compared to the group of on-pump CABG.,,,, Lower levels of CK-MB and troponin after OPCAB, showing better myocardial preservation, have also been observed.,,, Fortunately, there is no need for more inotropic support and no difference concerning arrhythmias frequency in the CABG group as it might be expected., Neither the meta-analysis by Møller et al. including 44 trials and approximately 4300 patients, nor this one by Cheng et al. managed to reveal any statistically significant difference concerning the extent of myocardial injury and other early postoperative complications between the two methods. Another study of MRI evaluation of viable myocardium after revascularization, comparing these two approaches, has failed to prove any significant difference between them although hemodynamic markers, such as cardiac biomarkers and end-systolic volume, were better preserved early postoperatively after OPCAB. A propensity score analysis by Kuss et al. also showed no statistically significant difference in the frequency of peri- and post-operative myocardial infarction although OPCAB group was superior to on-pump CABG group in terms of need for postoperative inotropic or mechanical support. Finally, neither a clinical trial by Alamanni et al. nor the meta-analysis by Wijeysundera et al. reported any significant difference between these two methods in the myocardial infarction rate and in residual ischemia rate. No significant difference in the incidence of perioperative myocardial infarction was either reported by Racz et al., Sabik et al., Reston et al., and Afilalo et al.
According to the meta-analysis by Møller et al. based on 30 trials including 3600 patients, OPCAB was related to a lower incidence of postoperative atrial fibrillation. A lower postoperative atrial fibrillation rate in favor of OPCAB was also reported by the meta-analysis by Cheng et al. examining 3300 patients of 37 randomized studies. Lower incidence of atrial fibrillation in OPCAB group was also reported among 6665 patients studied by Hu et al. as well as in 46,621 patients studied by Reston et al. However, the propensity score analyses by Kuss et al. did not confirm a statistically significant difference in atrial fibrillation occurrence between the two methods.
Neurological and neurocognitive damage
A significantly lower number of microemboli, mainly due to avoiding enboli-producing extracorporeal circulation and maneuvers on the thoracic aorta, has been reported since the beginning of OPCAB application compared to on-pump CABG.,, Indeed, the meta-analysis by Møller et al. showed a difference in favor of OPCAB although not statistically significant. No statistically significant difference in the incidence of strokes was either reported by Sabik et al. In contrast, a propensity score analyses by Kuss et al. reported statistically significant difference in neurological damage in favor of OPCAB. Significantly, higher incidence of stroke in ONCAB group was also reported by Racz et al. (2.0% vs. 1.6%; P = 0.003). Lower incidence of 30-day cerebrovascular accidents was also reported by Reston et al. As far as neurocognitive disorders are concerned, statistically significant higher occurrence has been demonstrated in the on-pump CABG group.,, This is especially true in the elderly, where their frequency after on-pump CABG is at least 4-fold that after OPCAB. However, Lamy et al. observed in the Coronary Artery Bypass Surgery Off or On-pump Revascularization Study (CORONARY) that although there was a small difference in cognitive function in favor of the off-pump group at discharge, this superiority did not persist after 1 year.
Contrary to what someone would expect, avoiding extracorporeal circulation does not prevent the kidney from a possible damage. Indeed, randomized comparative studies between the two methods did not demonstrate any superiority of OPCAB against on-pump CABG concerning renal complications.,,,, Similarly, the meta-analysis by Cheng et al. on 3300 patients reported no statistically significant difference between the two methods. However, Kuss et al. showed statistically significant superiority of OPCAB with regard to renal impairment in their propensity score analyses. Same results were reported by Racz et al., Sabik et al., and Reston et al., who observed less renal failure requiring dialysis related to OPCAB.
Left ventricle ejection fraction
The slight postoperative improvement of the ejection fraction of the left ventricle observed does not significantly differ depending on the method used. According to Puskas et al., there was not a significant difference in ejection fraction improvement even at 12 months postoperatively. The ejection fraction was improved from 54% to 61% in the OPCAB group, whereas it was improved from 53% to 59% in the on-pump CABG group.
| Intensive Care Unit and Hospital Stay Duration|| |
There are controversial results regarding Intensive Care Unit (ICU) and total hospital stay after OPCAB or on-pump CABG. There are few studies that show a statistically significant superiority of OPCAB in terms of ICU stay ,, or in terms of total hospital stay. A meta-analysis by Cheng et al. reported that patients submitted to on-pump CABG had a statistically significant longer ICU stay. This was due to increased respiratory complications, increased need for respiratory support, increased intubation time, and increased need for inotropes. Racz et al. reported a 1 day longer hospital stay when ONCAB was performed compared to OPCAB patients. On the other hand, Chu et al., who compared the hospital stay duration between patients submitted to OPCAB (n = 14.389) and those submitted to on-pump CABG (n = 48.658), reported longer hospital stay (by 0.6 days) when OPCAB was performed.
| Mid and Long-term Outcomes|| |
Most complaints raised against OPCAB concern the quality of peripheral anastomoses which will undoubtedly influence long-term graft patency. Indeed, there are some scientists who doubt about the quality of peripheral anastomoses and if complete revascularization is assured during OPCAB. According to a retrospective study by Amano et al., there was a statistically significant difference in favor of on-pump CABG in terms of event-free rate at 3 years. The event-free rate at 3 years was 88% after on-pump CABG against 84% after OPCAB. Khan et al. reported a significant superiority of OPCAB in graft patency at 3 months postoperatively (88% vs. 98%; P = 0.002). However, several randomized studies comparing long-term graft patency after OPCAB and after on-pump CABG, failed to show a statistically significant superiority of the latter.,,, In contrast, statistically significant greater long-term graft patency after on-pump CABG was reported by another study although it included a small number of patients. A meta-analysis by Takagi et al. showed that there is a statistically significant higher vein graft occlusion rate after OPCAB than after on-pump CABG.
Decreased need for reoperation is another indirect factor showing patency superiority. According to Hannan et al., patients submitted to OPCAB are significantly more prone to recurrence of angina and subsequent need for revascularization 3 years after their first revascularization operation. On the other hand, a randomized study by Puskas et al., including 200 patients did not show any statistically significant difference regarding graft restenosis, clinical recurrence of angina, myocardial infarction, and need for reperfusion between OPCAB and on-pump CABG. Similarly, a meta-analysis by Møller et al., including 15 trials with 2200 patients reported no statistically significant difference between the two methods. Feng's et al. meta-analysis including 10 randomized trials with about 2000 patients observed no significant difference in terms of reoperation frequency at 12 months after OPCAB or on-pump CABG. More interestingly, Reston's et al. meta-analysis showed that the recurrence of angina and subsequent need for reperfusion was higher at 3–25 months after on-pump CABG.
| Conversion Rate|| |
The need for conversion of OPCAB to conventional CABG is possible varying from 1% to 2%.,,, According to the recent Randomized On/Off Bypass trial, including 2203 patients, the conversion rate from OPCAB to ONCAB was 12.4%, which is significantly higher than the 2.2% found in the Society of Thoracic Surgeons database. This conversion rate was even lower in the CORONARY trial (7.9%). Limited surgical experience and 3-vessel disease make the conversion rate higher. Myocardial ischemia, anatomical unsuitability of the target vessel, and hemodynamic instability can be reasons why emergent intraoperative conversion should take place. Several studies have observed that emergent conversion from OPCAB to ONCAB is related to increased morbidity and mortality.,,,,, Mortality rates after conversion have ranged from 6% to 15%.,,,, According to a randomized study by Légaré et al., out of 150 patients, 20 patients (13%) whose OPCAB operation was converted to conventional CABG, were related to significantly higher mortality rate (10% vs. 0%), higher postoperative inotropic support requirements, and higher need for transfusion. Similar results regarding mortality were reported by Patel et al. (12% in-hospital mortality after conversion vs. 1.5% mortality without conversion) and by Jin et al., who observed in-hospital mortality rates as following (9.9% vs. 1.6% vs. 3.0% for converted to ONCAB patients, OPCAB patients without conversion and ONCAB patients, respectively).
| Quality of Life|| |
OPCAB has not managed to improve the quality of life compared to on-pump CABG.,,, According to Puskas et al., although the quality of life is significantly improved at 12 months postoperatively, there is no significant difference between OPCAB and on-pump CABG. However, OPCAB was superior to on-pump CABG in terms of postoperative social functioning. No significant difference between the two methods regarding quality of life was either observed by Lamy et al. in the CORONARY.
| Cost Comparison|| |
According to Scott et al., the total cost of the first surgery was significantly higher in the on-pump CABG group. According to a comparative study by Puskas et al., the mean cost for OPCAB- and particularly in the USA-is 17.000 dollars, whereas on-pump CABG costs 18.200 dollars on average. This difference is statistically significant in favor of OPCAB. Moreover, if this difference is calculated at 12 months postoperatively estimating possible rehospitalization, it is of the order of 1.900 dollars in favor of OPCAB. On the contrary, Chu et al. retrospectively compared the total cost of the patients' first hospitalization for OPCAB (n = 14.389) with this one for on-pump CABG (n = 48.658). The multivariable regression analysis showed a higher final cost by 1497 dollars per patient in those treated by OPCAB (P < 0.01).
| Conclusions|| |
Revascularization procedure without the use of extracorporeal circulation is a challenge for the surgeon. In spite of more difficult technical conditions, OPCAB offers to the patient reperfusion simultaneously preventing him from the deleterious effects of extracorporeal circulation. However, retrospective, nonrandomized, prospective randomized, and meta-analyses trials have not managed to show any significant improvement in short-term morbidity or mortality associated to OPCAB. Completeness of revascularization, technical precision, and anastomotic quality should not be compromised to avoid CPB. The surgeon should choose which technique he will perform depending on the case. Indeed, subgroups such as the elderly, patients with left main stem coronary artery disease, patients with functional impairment of the left ventricle, those having a calcified aorta (porcelain aorta), those suffering from the right coronary artery disease or NSTEMI infarction, as well as patients experiencing pulmonary hypertension or pulmonary edema seem to gain profit from the OPCAB procedure. High-risk subgroups such as women and diabetics may also be candidates for OPCAB.,, Finally, low-risk patients do not appear to take benefit from OPCAB application compared to the conventional on-pump CABG. However, conversion to ONCAB should be avoided as it is related to increased mortality rates.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Polomsky M, Puskas JD. Off-pump coronary artery bypass grafting – The current state. Circ J 2012;76:784-90.
Lazar HL. Should off-pump coronary artery bypass grafting be abandoned? Circulation 2013;128:406-13.
Briffa N. Off pump coronary artery bypass: A passing fad or ready for prime time? Eur Heart J 2008;29:1346-9.
Kerendi F, Morris CD, Puskas JD. Off-pump coronary bypass surgery for high-risk patients: Only in expert centers? Curr Opin Cardiol 2008;23:573-8.
Puskas J, Cheng D, Knight J, Angelini G, Decannier D, Diegeler A, et al.
Off-pump versus conventional coronary artery bypass grafting: A meta-analysis and consensus statement from the 2004 ISMICS consensus conference. Innovations (Phila) 2005;1:3-27.
Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al.
2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e652-735.
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, et al
. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
Nagpal AD, Bhatnagar G, Cutrara CA, Ahmed SM, McKenzie N, Quantz M, et al.
Early outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenarians. Can J Cardiol 2006;22:849-53.
Møller CH, Penninga L, Wetterslev J, Steinbrüchel DA, Gluud C. Clinical outcomes in randomized trials of off-vs. on-pump coronary artery bypass surgery: Systematic review with meta-analyses and trial sequential analyses. Eur Heart J 2008;29:2601-16.
Amano A, Hirose H, Takahashi A, Nagano N. Off-pump coronary artery bypass. Mid-term results. Jpn J Thorac Cardiovasc Surg 2001;49:67-78.
Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, et al.
On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009;361:1827-37.
Puskas JD, Kilgo PD, Kutner M, Pusca SV, Lattouf O, Guyton RA. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation 2007;116 11 Suppl: I192-9.
Racz MJ, Hannan EL, Isom OW, Subramanian VA, Jones RH, Gold JP, et al.
A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol 2004;43:557-64.
Hannan EL, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT, et al.
Off-pump versus on-pump coronary artery bypass graft surgery: Differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 2007;116:1145-52.
Li Z, Yeo KK, Parker JP, Mahendra G, Young JN, Amsterdam EA. Off-pump coronary artery bypass graft surgery in California, 2003 to 2005. Am Heart J 2008;156:1095-102.
Puskas JD, Edwards FH, Pappas PA, O'Brien S, Peterson ED, Kilgo P, et al.
Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. Ann Thorac Surg 2007;84:1447-54.
Chu D, Bakaeen FG, Dao TK, LeMaire SA, Coselli JS, Huh J. On-pump versus off-pump coronary artery bypass grafting in a cohort of 63,000 patients. Ann Thorac Surg 2009;87:1820-6.
Palmer G, Herbert MA, Prince SL, Williams JL, Magee MJ, Brown P, et al.
Coronary artery revascularization (CARE) registry: An observational study of on-pump and off-pump coronary artery revascularization. Ann Thorac Surg 2007;83:986-91.
Williams ML, Muhlbaier LH, Schroder JN, Hata JA, Peterson ED, Smith PK, et al.
Risk-adjusted short-and long-term outcomes for on-pump versus off-pump coronary artery bypass surgery. Circulation 2005;112 9 Suppl: I366-70.
Sabik JF, Blackstone EH, Lytle BW, Houghtaling PL, Gillinov AM, Cosgrove DM. Equivalent midterm outcomes after off-pump and on-pump coronary surgery. J Thorac Cardiovasc Surg 2004;127:142-8.
Cheng DC, Bainbridge D, Martin JE, Novick RJ; Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005;102:188-203.
Feng ZZ, Shi J, Zhao XW, Xu ZF. Meta-analysis of on-pump and off-pump coronary arterial revascularization. Ann Thorac Surg 2009;87:757-65.
Kuss O, von Salviati B, Börgermann J. Off-pump versus on-pump coronary artery bypass grafting: A systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg 2010;140:829-35.
Murzi M, Caputo M, Aresu G, Duggan S, Miceli A, Glauber M, et al.
On-pump and off-pump coronary artery bypass grafting in patients with left main stem disease: A propensity score analysis. J Thorac Cardiovasc Surg 2012;143:1382-8.
Jarral OA, Saso S, Athanasiou T. Off-pump coronary artery bypass in patients with left ventricular dysfunction: A meta-analysis. Ann Thorac Surg 2011;92:1686-94.
Fattouch K, Guccione F, Dioguardi P, Sampognaro R, Corrado E, Caruso M, et al.
Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: A randomized trial. J Thorac Cardiovasc Surg 2009;137:650-6.
Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, et al.
Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: A prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:797-808.
Straka Z, Widimsky P, Jirasek K, Stros P, Votava J, Vanek T, et al.
Off-pump versus on-pump coronary surgery: Final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg 2004;77:789-93.
Gerola LR, Buffolo E, Jasbik W, Botelho B, Bosco J, Brasil LA, et al.
Off-pump versus on-pump myocardial revascularization in low-risk patients with one or two vessel disease: Perioperative results in a multicenter randomized controlled trial. Ann Thorac Surg 2004;77:569-73.
Hu S, Zheng Z, Yuan X, Wang W, Song Y, Sun H, et al.
Increasing long-term major vascular events and resource consumption in patients receiving off-pump coronary artery bypass: A single-center prospective observational study. Circulation 2010;121:1800-8.
Reston JT, Tregear SJ, Turkelson CM. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 2003;76:1510-5.
Penttilä HJ, Lepojärvi MV, Kiviluoma KT, Kaukoranta PK, Hassinen IE, Peuhkurinen KJ. Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. Ann Thorac Surg 2001;71:565-71.
Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG, et al.
Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: A randomized trial. JAMA 2002;287:1405-12.
Ascione R, Reeves BC, Taylor FC, Seehra HK, Angelini GD. Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): Quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J 2004;25:765-70.
Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A, Neubauer S, et al.
Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345-50.
Alamanni F, Dainese L, Naliato M, Gregu S, Agrifoglio M, Polvani GL, et al.
On-and off-pump coronary surgery and perioperative myocardial infarction: An issue between incomplete and extensive revascularization. Eur J Cardiothorac Surg 2008;34:118-26.
Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, et al.
Off-pump coronary artery surgery for reducing mortality and morbidity: Meta-analysis of randomized and observational studies. J Am Coll Cardiol 2005;46:872-82.
Afilalo J, Rasti M, Ohayon SM, Shimony A, Eisenberg MJ. Off-pump vs. on-pump coronary artery bypass surgery: An updated meta-analysis and meta-regression of randomized trials. Eur Heart J 2012;33:1257-67.
Lund C, Hol PK, Lundblad R, Fosse E, Sundet K, Tennøe B, et al.
Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg 2003;76:765-70.
Abu-Omar Y, Cifelli A, Matthews PM, Taggart DP. The role of microembolisation in cerebral injury as defined by functional magnetic resonance imaging. Eur J Cardiothorac Surg 2004;26:586-91.
Motallebzadeh R, Kanagasabay R, Bland M, Kaski JC, Jahangiri M. S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2004;25:409-14.
Zamvar V, Williams D, Hall J, Payne N, Cann C, Young K, et al.
Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: Prospective randomised controlled trial. BMJ 2002;325:1268.
Lee JD, Lee SJ, Tsushima WT, Yamauchi H, Lau WT, Popper J, et al.
Benefits of off-pump bypass on neurologic and clinical morbidity: A prospective randomized trial. Ann Thorac Surg 2003;76:18-25.
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al.
Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med 2013;368:1179-88.
Angelini GD, Taylor FC, Reeves BC, Ascione R. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): A pooled analysis of two randomised controlled trials. Lancet 2002;359:1194-9.
Tang AT, Knott J, Nanson J, Hsu J, Haw MP, Ohri SK. A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients. Eur J Cardiothorac Surg 2002;22:118-23.
Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, et al.
Off-pump vs. conventional coronary artery bypass grafting: Early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 2004;291:1841-9.
Al-Ruzzeh S, George S, Bustami M, Wray J, Ilsley C, Athanasiou T, et al.
Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: Randomised controlled trial. BMJ 2006;332:1365.
Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, et al.
A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350:21-8.
Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, et al.
A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 2003;348:394-402.
Takagi H, Tanabashi T, Kawai N, Kato T, Umemoto T. Off-pump coronary artery bypass sacrifices graft patency: Meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2007;133:e2-3.
Ascione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study. Circulation 2000;102:1530-5.
Soltoski P, Salerno T, Levinsky L, Schmid S, Hasnain S, Diesfeld T, et al.
Conversion to cardiopulmonary bypass in off-pump coronary artery bypass grafting: Its effect on outcome. J Card Surg 1998;13:328-34.
Edgerton JR, Dewey TM, Magee MJ, Herbert MA, Prince SL, Jones KK, et al.
Conversion in off-pump coronary artery bypass grafting: An analysis of predictors and outcomes. Ann Thorac Surg 2003;76:1138-42.
Novick RJ, Fox SA, Stitt LW, Swinamer SA, Lehnhardt KR, Rayman R, et al.
Cumulative sum failure analysis of a policy change from on-pump to off-pump coronary artery bypass grafting. Ann Thorac Surg 2001;72:S1016-21.
Li Z, Denton T, Yeo KK, Parker JP, White R, Young JN, et al.
Off-pump bypass surgery and postoperative stroke: California coronary bypass outcomes reporting program. Ann Thorac Surg 2010;90:753-9.
Jin R, Hiratzka LF, Grunkemeier GL, Krause A, Page US 3rd
. Aborted off-pump coronary artery bypass patients have much worse outcomes than on-pump or successful off-pump patients. Circulation 2005;112 9 Suppl: I332-7.
Mukherjee D, Ahmed K, Baig K, Patel VM, Darzi A, Athanasiou T. Conversion and safety in off-pump coronary artery bypass: A system failure that needs re-emphasis. Ann Thorac Surg 2011;91:630-9.
Mukherjee D, Rao C, Ibrahim M, Ahmed K, Ashrafian H, Protopapas A, et al.
Meta-analysis of organ damage after conversion from off-pump coronary artery bypass procedures. Ann Thorac Surg 2011;92:755-61.
Vassiliades TA Jr., Nielsen JL, Lonquist JL. Hemodynamic collapse during off-pump coronary artery bypass grafting. Ann Thorac Surg 2002;73:1874-9.
Mathur AN, Pather R, Widjanarko J, Carrier RC, Garg R. Off-pump coronary artery bypass: The Sudbury experience. Can J Cardiol 2003;19:1261-9.
Iacò AL, Contini M, Teodori G, Di Mauro M, Di Giammarco G, Vitolla G, et al.
Off or on bypass: What is the safety threshold? Ann Thorac Surg 1999;68:1486-9.
Mujanovic E, Kabil E, Hadziselimovic M, Softic M, Azabagic A, Bergsland J. Conversions in off-pump coronary surgery. Heart Surg Forum 2003;6:135-7.
Légaré JF, Buth KJ, Hirsch GM. Conversion to on pump from OPCAB is associated with increased mortality: Results from a randomized controlled trial. Eur J Cardiothorac Surg 2005;27:296-301.
Patel NC, Patel NU, Loulmet DF, McCabe JC, Subramanian VA. Emergency conversion to cardiopulmonary bypass during attempted off-pump revascularization results in increased morbidity and mortality. J Thorac Cardiovasc Surg 2004;128:655-61.
Angelini GD, Culliford L, Smith DK, Hamilton MC, Murphy GJ, Ascione R, et al.
Effects of on-and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: Long-term follow-up of 2 randomized controlled trials. J Thorac Cardiovasc Surg 2009;137:295-303.
Kapetanakis EI, Stamou SC, Petro KR, Hill PC, Boyce SW, Bafi AS, et al.
Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery. J Card Surg 2008;23:120-5.
Scott BH, Seifert FC, Grimson R, Glass PS. Resource utilization in on-and off-pump coronary artery surgery: Factors influencing postoperative length of stay – An experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia. J Cardiothorac Vasc Anesth 2005;19:26-31.
Mack MJ, Pfister A, Bachand D, Emery R, Magee MJ, Connolly M, et al.
Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg 2004;127:167-73.
Emmert MY, Salzberg SP, Seifert B, Rodriguez H, Plass A, Hoerstrup SP, et al.
Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease? Eur J Cardiothorac Surg 2011;40:233-9.
Srinivasan AK, Grayson AD, Fabri BM. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: A propensity score analysis. Ann Thorac Surg 2004;78:1604-9.
Nikolaos A Papakonstantinou
12 Zilon Street, Rizoupoli 11142, Athens
Source of Support: None, Conflict of Interest: None